Based on this YouTube video's total view count of 591K views and industry-standard rates, the estimated total earning is $414 - $1.18K through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore Infection generates natural immunity with 591,450 views, 20,459 likes, and 4,930 comments. Experience the impact of this video content that has captured audience attention.

Which seems good and long lasting and cheap, lots of evidence below. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00676-9/fulltext Biological studies Dan et al (2021) Science, Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. https://www.science.org/doi/abs/10.1126/science.abf4063 95% of participants tested retained immune memory at about 6 months after having COVID-19 More than 90% of participants had CD4+ T-cell memory at 1 month, and 6–8 months after having COVID-19 Wang et al (2021) Science, Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants https://www.science.org/doi/abs/10.1126/science.abh1766 Previous SARS-CoV-2 infection, with an ancestral variant produce antibodies that cross-neutralise emerging variants of concern with high potency Epidemiological studies Hansen et al (2021) Lancet, Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(21)00575-4.pdf People who had had COVID-19 previously were around 80·5% protected against reinfection Pilz et al (2021) European Journal of Clinical Investigation, SARS-CoV-2 re-infection risk in Austria https://onlinelibrary.wiley.com/doi/full/10.1111/eci.13520 Sheehan et al (2021) Clinical Infectious Diseases, Reinfection rates among patients who previously tested positive for COVID-19: a retrospective cohort study https://academic.oup.com/cid/article/73/10/1882/6170939?login=true Shrestha et al (2021) Preprint, Necessity of COVID-19 vaccination in previously infected individuals https://www.medrxiv.org/content/10.1101/2021.06.01.21258176v3 Retrospective cohort study in the USA, People who had had COVID-19 previously were 100% protected against reinfection Gazit et al (2021) Preprint, Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections https://www.medrxiv.org/content/10.1101/2021.08.24.21262415.abstract Kojima et al (2021) Preprint, Incidence of severe acute respiratory syndrome coronavirus-2 infection among previously infected or vaccinated employees https://www.medrxiv.org/content/10.1101/2021.07.03.21259976v2 Laboratory staff routinely screened for SARS-CoV-2, people who had had COVID-19 previously were 100% protected against reinfection Clinical studies https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(21)00675-9.pdf Large, multicentre, prospective cohort study Previous COVID-19 diagnosis, 84% decreased risk of infection Letizia et al (2021) Lancet, Respiratory Medicine, SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study https://www.thelancet.com/pdfs/journals/lanres/PIIS2213-2600(21)00158-2.pdf Prospective cohort of US Marines, seropositive young adults were 82% protected against reinfection Adnan et al (2021) Clinical Infectious Diseases, Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients Undergoing Serial Laboratory Testing https://academic.oup.com/cid/article/74/2/294/6251701?login=false N = 9,119, serial tests Reinfection rates, 0.7% So Risk of repeat SARS-CoV-2 infection decreased by 80·5–100% among those who had had COVID-19 Protection from reinfection is strong and persists for more than 10 months of follow-up, (Hansen et al 2021 Lancet) Turner, et al Nature, SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans https://www.nature.com/articles/s41586-021-03647-4?amp%3Bcode=7bafb609-23c2-4665-804b Madhuumita et al, Plos One, T cell response to SARS-CoV-2 infection in humans: A systematic review https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0245532 SARS-CoV-2 infection induces specific and durable T-cell immunity, Nina et al, (2020) Nature, SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls https://www.nature.com/articles/s41586-020-2550-z?flip=true Memory B-cell response to SARS-CoV-2 evolves between 1·3 and 6·2 months after infection, which is consistent with longer-term protection Some people who have recovered from COVID-19 might not benefit from COVID-19 vaccination https://www.medrxiv.org/content/10.1101/2021.04.20.21255670v1 One study found that previous COVID-19 was associated with increased adverse events following vaccination with Pfizer https://www.journalofinfection.com/article/S0163-4453(21)00277-2/fulltext In Switzerland, proof of recovered infection, in the past 12 months are considered equally protected as fully vaccinated, https://www.schengenvisainfo.com/news/switzerland-plans-to-extend-covid-certificate-requirement-until-mid-november/

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.